Price trends before and after patent expiration in the pharmaceutical industry

Journal of Research in Pharmaceutical Economics

Volumn 9, Issue 2, 1998, Pages 17-32

  Suh, Dong Churl ^a   Schondelmeyer, Stephen W ^b   Manning Jr , Willard G ^c   Hadsall, Ronald S ^b   Nyman, John A ^c  

^a RUTGERS UNIVERSITY   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETOHEXAMIDE; AMILORIDE; BACLOFEN; BECLOMETASONE; CARBAMAZEPINE; CEFADROXIL; CEFALEXIN; CEFRADINE; CLINDAMYCIN; CLONIDINE; CLORAZEPATE; DANAZOL; DESIPRAMINE; DIAZEPAM; DISOPYRAMIDE; DOXEPIN; FLURAZEPAM; HALOPERIDOL; LACTULOSE; LORAZEPAM; MAPROTILINE; MECLOFENAMIC ACID; MESORIDAZINE; METHYLDOPA; METOCLOPRAMIDE; MOLINDONE; OXAZEPAM; PROPRANOLOL; SUCRALFATE; UNINDEXED DRUG;

ARTICLE; DRUG COST; DRUG INDUSTRY; DRUG MARKETING; PATENT; PRIORITY JOURNAL; PROSPECTIVE PRICING;

EID: 0031729446     PISSN: 08966621     EISSN: None     Source Type: Journal    
DOI: 10.1300/J063v09n02_03     Document Type: Article

References (27)

1. Cooper MH. Prices and profits in the pharmaceutical industry. Oxford, New York: Pergamon Press Inc., 1966.
2. Steele H. Patent restrictions and price competition in the ethical drugs industry. J Industrial Econ 1964;12:198-223.
3. Slatter SSP. Competition and marketing strategies in the pharmaceutical industry. New York: Holmes & Meier Publishers, Inc., 1977.
4. Schwartzman D. Innovation in the pharmaceutical industry. Baltimore, MD: Johns Hopkins University Press, 1976.
5. Temin P. Taking your medicine: drug regulation in the United States. Cambridge, MA: Harvard University Press, 1980.
6. Statman M, Tyebjee TT. Trademarks, patents, and innovation in the ethical drug industry. J Marketing 1981;45:71-80.
7. Grebmer KV. Competition in a structurally changing pharmaceutical market: some health economic considerations. Soc Sci Med 1981;15:77-86.
8. Hogan GF. Repercussions of the Drug Price Competition and Patent Term Restoration Act of 1984. Am J Hosp Pharm 1985;42:849-51.
9. Shacknai J. Trade secret under the Drug Price Competition and Patent Term Restoration Act of 1984. Food Drug Cosmetic Law J 1985;40:329-38.
10. Flannery EJ, Hutt PB. Balancing competition and patent protection in the drug industry: the Drug Price Competition and Patent Term Restoration Act of 1984. Food Drug Cosmetic Law J 1985;40:269-309.
11. Shah HK. The next decade in generic pharmaceuticals. Bus Q 1985;50:95-99.
12. Kaith KI, Trimble AG. Implementation of the Drug Price Competition and Patent Term Restoration Act of 1984: a progress report. J Clin Res Drug Dev 1987;1:263-75.
13. Statman M. The effect of patent expiration on the market position of drugs. In: Helms RB, ed. Drugs and health. Washington, DC: American Enterprise Institute for Public Policy Research, 1981:145-50.
14. Comanor WB. The political economy of the pharmaceutical industry. J Econ Lit 1986;24:1178-1217.
15. Grabowski HG, Vernon JM. Brand loyalty, entry and price competition in pharmaceuticals after the 1984 drug act. J Law Econ 1992;35:331-50.
16. Coster JM. Pharmaceutical pricing: balancing corporate objectives with society's needs. Pharmacy Practice Seminar Series. University of Minnesota College of Pharmacy, Minneapolis, MN, April 16, 1992.
17. Thomas J III, Schondelmeyer S. Price indices for pharmaceuticals used by the elderly. Health Care Finan Rev 1992;14:91-105.
18. Getzen TE. Medical care price indices: theory, construction and empirical analysis of the U.S. Series 1927-1990. Adv Health Econ Health Serv Res 1992;13:83-128.
19. Andersson F. Methodological aspects of international drug price comparisons. PharmacoEconomics 1993;4:247-56.
20. Andersson F. The GAO comparison of drug prices in the United States and Canada: are the prices really that much higher in the United States? J Res Pharm Econ 1995;6:3-20.
21. Fisher FM, Griliches Z. Aggregate price indices, new goods, and generics. Q J Econ 1995;110:229-244.
22. Council of Economic Advisers. Economic report of the President. Washington, DC: U.S. Government Printing Office, 1991:290.
23. Daniel WW, Terrell JC. Business statistics. Boston, MA: Houghton Mifflin Company, 1995.
24. Hamburg M. Statistical analysis for decision making. New York: Harcourt Brace Jovanovich Inc., 1977.
25. McClave JT, Benson PG. Statistics for business and economics. San Francisco, CA: Dellen Publishing Company, 1988.
26. Newbold P. Statistics for business and economics. Englewood Cliffs, NJ: Prentice Hall Inc., 1995.
27. Hausman JA. Specification tests in econometrics. Econometrica 1978; 46:1251-71.